PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8644700

Essential nutrients and immunologic functions.

D S Kelley·A Bendich
View original source ↗Export metadata ↓

Abstract

Several indexes of immune response, including responses on delayed-type hypersensitivity skin tests, antibody production, lymphocyte proliferation, cytokine production, and numbers of the specific subgroups of white blood cells, are influenced by essential nutrient intake and may serve as functional tests for evaluating nutritional status. In certain segments of the population, such as elderly persons and smokers, activity of the immune indexes can be increased through dietary supplementation with micronutrients, and there may be a rationale to increase selected recommended dietary allowances for the general population. The activity of the immune system may also be enhanced with decreases in total fat intake or lessened with increases in total fat intake, particularly of the n-3 type. Research to date, therefore, suggests that several dietary components, both essential and nonessential, can affect human immune response. The intake of these nutrients can be modulated to regulate the activity of the immune system.

Explore related subjects

Antibody FormationAscorbic AcidCarotenoidsCell DivisionCytokinesDietary FatsHumansImmune SystemLymphocytesNutritional RequirementsVitamin Ebeta CaroteneJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D S Kelley, A Bendich. 1996. Essential nutrients and immunologic functions.. https://doi.org/10.1093/ajcn%2F63.6.994

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells.

Thymic nurse cells are known to interact with T cells and play a role in their functional maturation. However, the role of nurse cells in B cell maturation and differentiation is less well established, especially at extralymphoid sites. To address this issue, nurse-like cell clones from bone marrow and synovial tissue of patients with RA (RA-NLC) were established and characterized. RA-NLC constitutively expressed CD29, CD49c, CD54 (ICAM-1), CD106 (VCAM-1), CD157 (BST-1), and class I MHC molecules, and secreted IL-6, IL-7, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF). Bone marrow-derived and synovial RA-NLC differed in that the former secreted IL-7 and expressed a greater density of CD157 constitutively and after stimulation with IFNgamma, whereas the latter secreted G-CSF and more IL-6. Stimulation of both bone marrow and synovial RA-NLC induced expression of CD40 and class II MHC, but not CD154 (CD40L) or CD35. RA-NLC rescued peripheral B cells from spontaneous apoptosis and promoted survival of B cells for > 4 wk. B cell survival was blocked by antibodies to CD106 or CD157. RA-NLC also increased Ig production from B cells. After long-term culture (4-6 wk) with RA-NLC, but not alone or with fibroblasts, outgrowth of B cells was observed. All B cell lines derived from these cultures had been transformed by EBV, although the RA-NLC themselves were not infected with EBV. Precursor frequency analysis indicated that approximately 1 in 12,500 peripheral B cells could give rise to these EBV-transformed B cell lines upon coculture with RA-NLC. These results indicate that RA-NLC from bone marrow and synovium have the capacity to rescue B cells from spontaneous apoptosis, facilitate Ig production, and promote the outgrowth of EBV-transformed B lymphoblastoid cells. These findings suggest that RA-NLC may play a role in the local and systemic hyperreactivity of B cells characteristic of rheumatoid arthritis.

Antibody Formation↗
PubMed1998

The antigenic structure of the HIV gp120 envelope glycoprotein.

The human immunodeficiency virus HIV-1 establishes persistent infections in humans which lead to acquired immunodeficiency syndrome (AIDS). The HIV-1 envelope glycoproteins, gp120 and gp41, are assembled into a trimeric complex that mediates virus entry into target cells. HIV-1 entry depends on the sequential interaction of the gp120 exterior envelope glycoprotein with the receptors on the cell, CD4 and members of the chemokine receptor family. The gp120 glycoprotein, which can be shed from the envelope complex, elicits both virus-neutralizing and non-neutralizing antibodies during natural infection. Antibodies that lack neutralizing activity are often directed against the gp120 regions that are occluded on the assembled trimer and which are exposed only upon shedding. Neutralizing antibodies, by contrast, must access the functional envelope glycoprotein complex and typically recognize conserved or variable epitopes near the receptor-binding regions. Here we describe the spatial organization of conserved neutralization epitopes on gp120, using epitope maps in conjunction with the X-ray crystal structure of a ternary complex that includes a gp120 core, CD4 and a neutralizing antibody. A large fraction of the predicted accessible surface of gp120 in the trimer is composed of variable, heavily glycosylated core and loop structures that surround the receptor-binding regions. Understanding the structural basis for the ability of HIV-1 to evade the humoral immune response should assist in the design of a vaccine.

Antibody Formation↗